Investigating how TET1 affects germ cell development and reprogramming
Role of TET1 in germ cell reprogramming and development
This study is looking at how a special enzyme called TET1 helps make sure that germ cells, which are important for reproduction, develop correctly to avoid genetic issues in future generations, and it's designed for anyone interested in understanding fertility and genetic health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10877811 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the TET1 enzyme in the reprogramming of germ cells, which is essential for proper development and the prevention of genetic abnormalities in offspring. The study will utilize advanced mouse models and sequencing technologies to explore how TET1 facilitates the removal of DNA methylation and histone modifications, ensuring that germ cells develop with the correct epigenetic patterns. By examining the mechanisms of TET1, researchers aim to uncover its critical functions in both germline and somatic development, which could have implications for fertility and genetic health.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals under 21 years old who may be experiencing fertility issues or genetic concerns related to germ cell development.
Not a fit: Patients who are not experiencing fertility issues or genetic abnormalities may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of fertility issues and genetic transmission, potentially benefiting patients facing reproductive challenges.
How similar studies have performed: Previous research has shown promising results in understanding the roles of TET enzymes in epigenetic regulation, suggesting that this approach could yield significant insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Bartolomei, Marisa S. — University of Pennsylvania
- Study coordinator: Bartolomei, Marisa S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.